Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shiho Hirano

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Royal Society Open Science|July 18, 2019
Biomimetic synthesis of nanostructured WO<sub>3</sub> · H<sub>2</sub>O particles and subsequent thermal conversion to WO<sub>3</sub>Hiroaki Uchiyama, Shouta Mizuguchi, Shiho Hirano
Journal for Immunotherapy of Cancer|March 11, 2026
CD79A/CD40 intracellular domain uses a 4-1BB-like metabolic pathway driven by cholesterol biosynthesisYuki Takeuchi, Seitaro Terakura, Kohei Ishigiwa, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|August 6, 2023
[Diffuse large B-cell lymphoma expressing high-level glyceraldehyde 3-phosphate dehydrogenase complicated with hypoglycemia]Shiho Hirano, Akari Iwakoshi, Nobuhiko Imahashi, et al.
International Journal of Hematology|February 27, 2025
Simple and early prediction of severe CAR-T-related adverse events after Axi-cel infusion by initial high feverHiroya Wakabayashi, Seitaro Terakura, Kohei Ishigiwa, et al.
British Journal of Haematology|May 25, 2025
Robust CAR T-cell expansion and superior outcomes in DLBCL patients in complete response at infusionRyo Hanajiri, Hiroya Wakabayashi, Kohei Ishigiwa, et al.
Journal for Immunotherapy of Cancer|May 9, 2025
Development and optimization of Eva1 (<i>MPZL2</i>) targeting chimeric antigen receptor T cellsMasahide Osaki, Seitaro Terakura, Shiho Hirano, et al.
Cytotherapy|June 17, 2025
Adjustment of low-dose ATG exposure improves outcomes in allogeneic hematopoietic stem cell transplantation: a prospective multicenter studyShihomi Kuwano, Seitaro Terakura, Kanae Imai, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Royal Society Open Science|July 18, 2019
Biomimetic synthesis of nanostructured WO<sub>3</sub> · H<sub>2</sub>O particles and subsequent thermal conversion to WO<sub>3</sub>Hiroaki Uchiyama, Shouta Mizuguchi, Shiho Hirano
Journal for Immunotherapy of Cancer|March 11, 2026
CD79A/CD40 intracellular domain uses a 4-1BB-like metabolic pathway driven by cholesterol biosynthesisYuki Takeuchi, Seitaro Terakura, Kohei Ishigiwa, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|August 6, 2023
[Diffuse large B-cell lymphoma expressing high-level glyceraldehyde 3-phosphate dehydrogenase complicated with hypoglycemia]Shiho Hirano, Akari Iwakoshi, Nobuhiko Imahashi, et al.
International Journal of Hematology|February 27, 2025
Simple and early prediction of severe CAR-T-related adverse events after Axi-cel infusion by initial high feverHiroya Wakabayashi, Seitaro Terakura, Kohei Ishigiwa, et al.
British Journal of Haematology|May 25, 2025
Robust CAR T-cell expansion and superior outcomes in DLBCL patients in complete response at infusionRyo Hanajiri, Hiroya Wakabayashi, Kohei Ishigiwa, et al.
Journal for Immunotherapy of Cancer|May 9, 2025
Development and optimization of Eva1 (<i>MPZL2</i>) targeting chimeric antigen receptor T cellsMasahide Osaki, Seitaro Terakura, Shiho Hirano, et al.
Cytotherapy|June 17, 2025
Adjustment of low-dose ATG exposure improves outcomes in allogeneic hematopoietic stem cell transplantation: a prospective multicenter studyShihomi Kuwano, Seitaro Terakura, Kanae Imai, et al.
Pageof 1